Testing a genetic difference in CLL
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at a specific gene variant in people with newly diagnosed chronic lymphocytic leukemia (CLL). It may help researchers understand CLL better and how genetics could affect the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been newly diagnosed with chronic lymphocytic leukemia (CLL).
- You have not been previously treated for CLL before this study.
- You do not have any other solid cancer (tumors).
- You are able to be assessed for study eligibility based on these criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how the body makes blood cells in people with chronic lymphocytic leukemia (CLL), a related condition called monoclonal B-cell lymphocytosis (MBL), and in healthy volunteers matched by age. The goal is to understand differences that may help improve treatment or monitoring.
This study measures how your body’s metabolism works in people with chronic lymphocytic leukemia (CLL). It uses blood tests, and for some people, a bone marrow sample, to better understand what’s happening and potentially guide future treatments.
This study aims to learn more about chronic lymphocytic leukemia (CLL) and closely related conditions. It may help researchers better understand who gets CLL and how it behaves over time, which can improve future care.
This Phase 3 trial studies an early treatment approach for people with high-risk CLL or SLL who have not yet needed standard therapy. It aims to see if treating earlier can improve outcomes while keeping side effects manageable.
This registry collects information over time from people with CLL to better understand the disease and its treatment. It does not test any new drugs or procedures.
This study looks at blood tests and genetic markers in people newly diagnosed with chronic lymphocytic leukemia (CLL). It aims to better understand the disease and may help guide future care.
Hear when a new Chronic Lymphocytic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.